CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
79 hedge funds and large institutions have $219M invested in Concert Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 79 → 79 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
79
Holding in Top 10
2
Calls
$592K
Puts
$220K
Top Buyers
| 1 | +$18.9M | |
| 2 | +$3.81M | |
| 3 | +$2.91M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.37M |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
+$2.26M |
Top Sellers
| 1 | -$6.68M | |
| 2 | -$5.18M | |
| 3 | -$3.33M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.5M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$1.13M |